O Estudo SORAMIC

SORAMIC é o primeiro grande ensaio clínico randomizado (ECR) a comparar a eficácia e a segurança da combinação das microesferas de resina sorafenib e SIR-Spheres® Y-90 com o sorafenib isolado no tratamento do CHC na coorte paliativa. Pacientes com CHC que participaram do corte paliativo do estudo SORAMIC não eram elegíveis para ressecção ou ablação, e não eram candidatos ideais para quimioembolização transarterial (TACE).

 

O objetivo primário do suporte paliativo do estudo SORAMIC é Sobrevivência Geral (OS). Os endpoints secundários incluem Safety e OS para pacientes com e sem trombose da veia porta.

 

Os resultados do estudo SORAMIC são esperados para 2018.

 




Now leaving sirtex.com

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.

Continue

×

Now leaving sirtex.com

You are about to leave the Sirtex Website. This link is provided to you as a service and will take you to the Sirtex Virtual Booth.

Sirtex is responsible for the content of the Virtual Booth, which is hosted on a website maintained by a third-party. Except for Sirtex’s Virtual Booth experience, please be aware that Sirtex takes no responsibility for the other content of these external sites, nor do we endorse, warrant, or guarantee the products, services or information described or offered on other internet sites.

Continue

×

You are now leaving your current sirtex.com region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.

Continue

×